Share Twitter LinkedIn Facebook Email Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains how the landscape is changing in treating metastatic hormone-sensitive prostate cancer. Advertisement
Alcohol Consumption and Cancer Risk: Insights from the 2025 Surgeon General’s Advisory Breast Cancer 3 Mins Read
Genitourinary Cancer [2025] Treatment Breakthroughs: ASCO GU 2025 Highlights Nataliya Mar, MD – MOASC Genitourinary 6 Mins Read